Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (Q73112077)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1997

Language	Label	Description	Also known as
English	Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL	scientific article published on 01 January 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

O Hussein

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Schlezinger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Rosenblat

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Keidar

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Aviram

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 January 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

11-18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Modified forms of low density lipoprotein and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Fibrates and statins in the treatment of hyperlipidaemia: an appraisal of their efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Effets of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Pharmacokinetics of fluvastatin and specific drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Antioxidant defenses and lipid peroxidation in human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Antioxidant Determinations by the Use of a Stable Free Radical

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905972-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(96)05972-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9051193%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73112077&oldid=2218649411"